Form 4 for TDOC Teladoc Health, Inc.
Accepted 2026-03-12 00:00:00 ET · period of report 2026-03-10 · accession 0001347535-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-12 | 2026-03-11 | TDOC | DIVITA CHARLES III | CEO, Dir | S - Sale+OE | $5.49 | -27.7K | 364.8K | -7% | -$152.2K |
| DM | 2026-03-12 | 2026-03-10 | TDOC | DIVITA CHARLES III | CEO, Dir | M - OptEx | — | +64.7K | 392.5K | +20% | — |
| DM | 2026-03-12 | 2026-03-10 | TDOC | DIVITA CHARLES III | CEO, Dir | M - OptEx | $0.00 | -64.7K | 195.8K | -25% | $0 |
| D | 2026-03-12 | 2026-03-10 | TDOC | DIVITA CHARLES III | CEO, Dir | A - Grant | $0.00 | +43.7K | 43.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-11 | S | D | 27,731 | $5.49 | 364,784 | D | — | — | (F3) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| 2 | Common | Common Stock | 2026-03-10 | M | A | 39,160 | — | 367,022 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 3 | Common | Common Stock | 2026-03-10 | M | A | 25,493 | — | 392,515 | D | — | — | (F2) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 4 | Derivative | Performance Stock Units | 2026-03-10 | M | D | 25,493 | $0.00 | 18,210 | D | — · — to — | 25,493 Common Stock | (F2) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. (F8) On March 10, 2026, the reporting person earned 43,703 performance stock units, vesting seven-twelfths on March 10, 2026, with the remainder vesting in five substantially equal quarterly installments over the subsequent 15 months. |
| 5 | Derivative | Performance Stock Units | 2026-03-10 | A | A | 43,703 | $0.00 | 43,703 | D | — · — to — | 43,703 Common Stock | (F6) Performance award amount determined based on metrics in respect of the issuer's 2025 financial results. (F5) Each performance stock unit represents a contingent right to receive one share of TDOC common stock. (F7) The performance stock units vest as to seven-twelfths on March 10, 2026, with the remainder vesting in five substantially equal quarterly installments over the subsequent 15 months. |
| 6 | Derivative | Restricted Stock Units | 2026-03-10 | M | D | 39,160 | $0.00 | 195,803 | D | — · — to — | 39,160 Common Stock | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F4) On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |